14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $76.39 Friday, 3rd May 2024 AXSM stock ended at $74.80. This is 0.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.64% from a day low at $74.36 to a day high of $76.32.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Jul 24, 2020 $79.26 $79.68 $76.81 $77.35 346 801
Jul 23, 2020 $81.94 $83.50 $79.37 $79.90 256 516
Jul 22, 2020 $81.65 $82.30 $79.16 $81.82 254 800
Jul 21, 2020 $84.24 $85.25 $81.34 $81.88 390 100
Jul 20, 2020 $81.32 $85.05 $80.66 $83.51 353 100
Jul 17, 2020 $80.00 $84.70 $79.87 $81.65 346 100
Jul 16, 2020 $81.31 $81.39 $77.09 $80.00 351 800
Jul 15, 2020 $80.27 $82.76 $78.59 $82.09 395 200
Jul 14, 2020 $77.52 $79.88 $76.27 $79.42 399 500
Jul 13, 2020 $83.01 $84.10 $76.47 $76.74 600 400
Jul 10, 2020 $81.98 $83.83 $80.02 $83.04 304 100
Jul 09, 2020 $85.98 $87.25 $81.50 $81.92 441 600
Jul 08, 2020 $83.96 $85.87 $82.16 $85.84 382 500
Jul 07, 2020 $81.09 $85.50 $80.90 $83.88 365 700
Jul 06, 2020 $82.09 $83.78 $81.22 $82.01 299 900
Jul 02, 2020 $84.33 $84.67 $80.68 $80.97 499 072
Jul 01, 2020 $82.35 $85.63 $81.12 $83.91 388 148
Jun 30, 2020 $77.51 $83.90 $77.36 $82.28 1 285 118
Jun 29, 2020 $86.29 $87.00 $75.00 $76.36 1 421 689
Jun 26, 2020 $82.94 $89.26 $82.94 $85.79 2 296 677
Jun 25, 2020 $75.67 $77.44 $74.17 $76.61 311 845
Jun 24, 2020 $77.95 $78.50 $74.29 $75.41 349 233
Jun 23, 2020 $78.91 $80.60 $77.80 $78.95 457 053
Jun 22, 2020 $80.12 $81.54 $75.61 $78.59 579 778
Jun 19, 2020 $77.68 $80.44 $77.02 $79.56 821 765
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT